Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2401 AL 2415

Spatial transcriptomics reveals molecular dysfunction associated with Lewy pathology

Goralski T, Meyerdirk L, Breton L, Brasseur L, Kurgat K, DeWeerd D, Turner L, Becker K, Adams M, Newhouse D, Henderson MX.

bioRxiv [Preprint]. 2023 May 17:2023.05.17.541144. doi: 10.1101/2023.05.17.541144.

Parallel Neurodegenerative Phenotypes in Sporadic Parkinson's Disease Fibroblasts and Midbrain Dopamine Neurons

Corenblum MJ, McRobbie-Johnson A, Carruth E, Bernard K, Luo M, Mandarino LJ, Peterson S, Billheimer D, Maley T, Eggers ED, Madhavan L.

bioRxiv [Preprint]. 2023 Feb 12:2023.02.10.527867. doi: 10.1101/2023.02.10.527867.

Curriculum Based Multi-Task Learning for Parkinson's Disease Detection

Dhinagar NJ, Owens-Walton C, Laltoo E, Boyle CP, Chen YL, Cook P, McMillan C, Tsai CC, Wang JJ, Wu YR, van der Werf Y, Thompson PM.

ArXiv [Preprint]. 2023 Feb 27:arXiv:2302.13631v1.

Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseases

Billings JL, Hilton JBW, Liddell JR, Hare DJ, Crouch PJ.

J Neurochem. 2023 Nov;167(3):337-346. doi: 10.1111/jnc.15978. Epub 2023 Oct 6.

Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesia

Sosero YL, Bandres-Ciga S, Ferwerda B, Tocino MTP, Belloso DR, Gómez-Garre P, Faouzi J, Taba P, Pavelka L, Marques TM, Gomes CPC, Kolodkin A, May P, Milanowski LM, Wszolek ZK, Uitti RJ, Heutink P, van Hilten JJ, Simon DK, Eberly S, Alvarez I, Krohn L, Yu E, Freeman K, Rudakou U, Ruskey JA, Asayesh F, Menéndez-Gonzàlez M, Pastor P, Ross OA, Krüger R, Corvol JC, Koks S, Mir P, De Bie RMA, Iwaki H, Gan-Or Z.

medRxiv [Preprint]. 2023 Sep 20:2023.08.28.23294610. doi: 10.1101/2023.08.28.23294610.

Meta-analysis of the effect of whole-body vibration training on the improvement of limb function in patients with Parkinson's disease

Zhao YG, Lv W, Huo HQ, Wu JR, Cheng WW, Wang S.

Eur Rev Med Pharmacol Sci. 2023 Aug;27(15):6985-6995. doi: 10.26355/eurrev_202308_33270.

Ambient temperature and nervous system diseases-related mortality in Japan from 2010 to 2019: A time-stratified case-crossover analysis

Lin SY, Ng CFS, Kim Y, Htay ZW, Cao AQ, Pan R, Hashizume M.

Sci Total Environ. 2023 Apr 1;867:161464. doi: 10.1016/j.scitotenv.2023.161464. Epub 2023 Jan 6.

Biopsychosocial effects and experience of use of robotic and virtual reality devices in neuromotor rehabilitation: A study protocol

Zanatta F, Steca P, Fundarò C, Giardini A, Felicetti G, Panigazzi M, Arbasi G, Grilli C, D'Addario M, Pierobon A.

PLoS One. 2023 Mar 10;18(3):e0282925. doi: 10.1371/journal.pone.0282925. eCollection 2023.

Comparison of Anatomical and Diffusion MRI for detecting Parkinson's Disease using Deep Convolutional Neural Network

Chattopadhyay T, Singh A, Laltoo E, Boyle CP, Owens-Walton C, Chen YL, Cook P, McMillan C, Tsai CC, Wang JJ, Wu YR, van der Werf Y, Thompson PM.

bioRxiv [Preprint]. 2023 May 1:2023.05.01.538952. doi: 10.1101/2023.05.01.538952.

Effects of high-intensity respiratory muscle training on respiratory muscle strength in individuals with Parkinson's disease: Protocol of a randomized clinical trial

Brito SAF, Scianni AA, Silveira BMF, Oliveira ERM, Mateus ME, Faria CDCM.

PLoS One. 2023 Sep 8;18(9):e0291051. doi: 10.1371/journal.pone.0291051. eCollection 2023.

Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)

Winter-van Rossum I, Weiser M, Galderisi S, Leucht S, Bitter I, Glenthøj B, Hasan A, Luykx J, Kupchik M, Psota G, Rocca P, Stefanis N, Teitelbaum A, Bar Haim M, Leucht C, Kemmler G, Schurr T; EULAST Study Group; Davidson M, Kahn RS, Fleischhacker WW.

Lancet Psychiatry. 2023 Mar;10(3):197-208. doi: 10.1016/S2215-0366(23)00005-6. Epub 2023 Jan 27.

Ultra-high-field 7T MRI in Parkinson's disease: ready for clinical use?-a narrative review

Welton T, Hartono S, Shih YC, Schwarz ST, Xing Y, Tan EK, Auer DP, Harel N, Chan LL.

Quant Imaging Med Surg. 2023 Nov 1;13(11):7607-7620. doi: 10.21037/qims-23-509. Epub 2023 Oct 17.

Functional movement disorder comorbidity in Parkinson's disease: A multicenter descriptive study

Delgado C, Lopez-Jimenez A, Lopez-Valdes E, Gomez-Mayordomo V, Baltasar-Corral A, Martínez-Castrillo JC, Alonso-Canovas A, Tabar G, García-Ruiz PJ, de la Fuente S, Vela-Desojo L, Pareés I, Kurtis MM.

Parkinsonism Relat Disord. 2023 Sep;114:105776. doi: 10.1016/j.parkreldis.2023.105776. Epub 2023 Jul 29.

Hard to swallow? A review into dysphagia care in patients with Parkinson's disease

Koomson D, Freeth H, Goodwin A, Srivastava V.

Br J Hosp Med (Lond). 2023 Feb 2;84(2):1-4. doi: 10.12968/hmed.2022.0497. Epub 2023 Feb 9.

Conceptualization, Measurement, and Factors Associated with Participation in Parkinson's Disease: A Systematic Review and Qualitative Analysis

Kim MY, Jethani P, Kang E, Lipsey KL, Foster ER.

Arch Phys Med Rehabil. 2023 Oct 28:S0003-9993(23)00602-0. doi: 10.1016/j.apmr.2023.10.009. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias